MMP2 and osteosarcoma: Previous studies have revealed that SPAG5 silencing decreases matrix metalloproteinase-2 (MMP2) expression by downregulating FOXM1 to curb osteosarcoma (OS) cell invasion, migration, metastasis, and epithelial-mesenchymal transition (EMT) [14].